Condition
Cutaneous T-cell Lymphoma (CTCL) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Cutaneous T-cell Lymphoma (CTCL) clinical trials that are recruiting, at sites in 2 countries (most in China (3), United States (1)). By phase: Phase 1/2 (1), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Cutaneous T-cell Lymphoma (CTCL) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Golidocitinib and chidamide for cutaneous T-cell lymphoma | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Aug 10, 2026 |
| Evaluating CHT101 for patients with specific blood cancers | Phase 1 | Tianjin, Tianjin Municipality | Recruiting | Apr 6, 2025 |
| Golidocitnib treatment for relapsed indolent T/NK-cell lymphomas | Phase 2 | Tianjin, Tianjin Municipality and 1 other locations | Recruiting | Dec 4, 2024 |
| Collecting samples to study hairy cell leukemia and develop new cancer treatments | — | Bethesda, Maryland | Recruiting | Mar 16, 2010 |
All recruiting trials (4)
-
Golidocitinib and chidamide for cutaneous T-cell lymphoma
This study tests whether the combo of golidocitinib and chidamide helps people with CTCL that has already received prior systemic therapy.
-
Evaluating CHT101 for patients with specific blood cancers
This study is testing a new treatment called CHT101 to see if it can help people with certain types of blood cancers that have come back or didn’t respond to other treatments.
-
Golidocitnib treatment for relapsed indolent T/NK-cell lymphomas
This study is testing if a new oral medication called Golidocitnib can help people with relapsed indolent T/NK-cell lymphomas feel better after other treatments haven't worked.
-
Collecting samples to study hairy cell leukemia and develop new cancer treatments
This study is collecting samples from people with hairy cell leukemia and healthy volunteers to see if new treatments can be developed to better fight this type of cancer.
Related topics
Quick answers
How many Cutaneous T-cell Lymphoma (CTCL) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (3 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.